title: The alteration of 18F-FDG uptake in bone marrow after treatment with interleukin 11.
abstract: Diffuse increased F-FDG in the bone marrow can be seen with colony-stimulating factors. Here, we reported a case of idiopathic cytopenia of undetermined significance treated with interleukin 11. After administration of interleukin 11, both diffuse and focally increased FDG activity in the bone marrow were noted. The focal activity was histologically proven as hyperplastic bone marrow.
authors.affiliation: From the Department of Nuclear Medicine, the First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
authors.forename: Chang
authors.initials: C
authors.lastname: Yi
authors.forename: Xinchong
authors.initials: X
authors.lastname: Shi
authors.forename: Xiaoyan
authors.initials: X
authors.lastname: Wang
authors.forename: Zhifeng
authors.initials: Z
authors.lastname: Chen
authors.forename: Bing
authors.initials: B
authors.lastname: Zhang
authors.forename: Xiangsong
authors.initials: X
authors.lastname: Zhang
mesh_terms: D001853:Bone Marrow / Q000000981:diagnostic imaging* / Q000187:drug effects; D019788:Fluorodeoxyglucose F18 / Q000493:pharmacokinetics*; D006801:Humans; D017370:Interleukin-11 / Q000494:pharmacology* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals / Q000493:pharmacokinetics*; D013921:Thrombocytopenia / Q000188:drug therapy
chemical_list: D017370:Interleukin-11; D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18